A one-time treatment for a devastating rare disease could be paid for with an installment plan as soon as this summer in Massachusetts. Novartis’s AveXis unit is involved in the discussions. Its gene therapy could cost up to $5 million per treatment. Organizers hope the plan will ensure patients can access a potentially life-changing treatment. Business Insider is the first to report on the discussions and the interest from AveXis.
In recent years, no